{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:50:09Z","timestamp":1793047809243,"version":"4.5.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>There are few studies reporting frequency and control of adverse events associated with congenital toxoplasmosis treatment. The objective of this study is to describe treatment adherence and adverse hematologic events in a cohort of children identified with congenital toxoplasmosis in Minas Gerais, Brazil.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Children were treated with sulfadiazine, pyrimethamine and folinic acid and were evaluated clinically and by laboratory tests at regular intervals.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of 146,307 live newborns who participated in the Neonatal Screening Program in Minas Gerais in 2006\u20132007, 190 had congenital toxoplasmosis. Among the 171 children whose treatment data were available, 73.1% completely adhered to antiparasitic therapy. Hematologic adverse events (macrocytic anemia and\/or neutropenia and\/or thrombocytopenia) were diagnosed in 44% of them. The most common adverse event was neutropenia (31%). In most cases, it was not severe and reversed after increase in folinic acid dosage (25.7%) or temporary treatment suspension (1.8%). No infections were observed in association with neutropenic events. Significant associations were detected between macrocytic anemia and lower weight Z score at first medical appointment (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.03), and between severe neutropenia (&lt;500\/mm<jats:sup>3<\/jats:sup>) and lower weight Z score toward the end of treatment (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.04).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The high frequency of hematologic adverse events found, especially in malnourished children, highlight the importance of careful monitoring of these children throughout treatment, as well as considering nutritional aspects and the need for higher doses of folinic acid. With adequate monitoring, antiparasitic treatment was feasible and relatively safe in the setting of this large screening program for congenital toxoplasmosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000001561","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T11:57:16Z","timestamp":1486727836000},"page":"1169-1176","source":"Crossref","is-referenced-by-count":14,"title":["High Frequency of Bone Marrow Depression During Congenital Toxoplasmosis Therapy in a Cohort of Children Identified by Neonatal Screening in Minas Gerais, Brazil"],"prefix":"10.1097","volume":"36","author":[{"given":"Ericka Viana Machado","family":"Carellos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Queiroz","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Maia Castro","family":"Romanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline Domingos","family":"Tib\u00farcio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 N\u00e9lio","family":"Janu\u00e1rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel V\u00edtor","family":"Vasconcelos-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ros\u00e2ngela Maria","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gl\u00e1ucia Manzan Queiroz","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20231020","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1542\/peds.113.6.1567","article-title":"Long-term ocular prognosis in 327 children with congenital toxoplasmosis.","volume":"113","author":"Wallon","year":"2004","journal-title":"Pediatrics"},{"key":"R3-20231020","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ophtha.2007.06.022","article-title":"Longitudinal study of new eye lesions in treated congenital toxoplasmosis.","volume":"115","author":"Phan","year":"2008","journal-title":"Ophthalmology"},{"key":"R4-20231020","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1590\/S0074-02762009000200029","article-title":"Why prevent, diagnose and treat congenital toxoplasmosis?","volume":"104","author":"McLeod","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"R5-20231020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1590\/S0074-02762009000200026","article-title":"Treatment for congenital toxoplasmosis: finding out what works.","volume":"104","author":"Gilbert","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"R8-20231020","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.ophtha.2009.04.042","article-title":"Congenital toxoplasmosis in southeastern Brazil: results of early ophthalmologic examination of a large cohort of neonates.","volume":"116","author":"Vasconcelos-Santos","year":"2009","journal-title":"Ophthalmology"},{"key":"R9-20231020","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/BF01701522","article-title":"Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis.","volume":"15","author":"Lebech","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R10-20231020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/clinids\/18.1.38","article-title":"Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial.","volume":"18","author":"McAuley","year":"1994","journal-title":"Clin Infect Dis"},{"key":"R13-20231020","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication.","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"R14-20231020","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/501360","article-title":"Outcome of treatment for congenital toxoplasmosis, 1981\u20132004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.","volume":"42","author":"McLeod","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R15-20231020","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1056\/NEJM199406303302604","article-title":"Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group.","volume":"330","author":"Guerina","year":"1994","journal-title":"N Engl J Med"},{"key":"R16-20231020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1749-6632.2000.tb05504.x","article-title":"Factors with a negative influence on compliance to antiretroviral therapies.","volume":"918","author":"Cupsa","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"R17-20231020","first-page":"189","article-title":"The challenge of patient adherence.","volume":"1","author":"Martin","year":"2005","journal-title":"Ther Clin Risk Manag"},{"key":"R18-20231020","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/INF.0b013e31816dd325","article-title":"A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries.","volume":"27","author":"Vreeman","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R19-20231020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fphar.2013.00091","article-title":"Determinants of patient adherence: a review of systematic reviews.","volume":"4","author":"Kardas","year":"2013","journal-title":"Front Pharmacol"},{"key":"R20-20231020","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/bjo.40.10.577","article-title":"Treatment of uveitis with pyrimethamine (daraprim).","volume":"40","author":"Perkins","year":"1956","journal-title":"Br J Ophthalmol"},{"key":"R21-20231020","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1001\/archopht.1960.01840010142016","article-title":"The hematologic toxicity of pyrimethamine (daraprim) in man.","volume":"64","author":"Kaufman","year":"1960","journal-title":"Arch Ophthalmol"},{"key":"R22-20231020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archopht.1964.00970010074010","article-title":"Toxoplasmic retinochoroiditis: a double blind therapeutic study.","volume":"71","author":"Acers","year":"1964","journal-title":"Arch Ophthalmol"},{"key":"R23-20231020","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9394(14)74456-3","article-title":"Therapy for ocular toxoplasmosis.","volume":"115","author":"Rothova","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"R24-20231020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0929-693X(01)00687-X","article-title":"Treatment of subclinical congenital toxoplasmosis by sulfadiazine and pyrimethamine continuously during 1 year: apropos of 46 cases.","volume":"9","author":"Kieffer","year":"2002","journal-title":"Arch Pediatr"},{"key":"R25-20231020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0002-9394(02)01537-4","article-title":"A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis.","volume":"134","author":"Bosch-Driessen","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R26-20231020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00431-005-1665-4","article-title":"Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine.","volume":"165","author":"Schmidt","year":"2006","journal-title":"Eur J Pediatr"},{"key":"R27-20231020","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.bjid.2013.11.009","article-title":"Congenital toxoplasmosis in a reference center of Paran\u00e1, Southern Brazil.","volume":"18","author":"Capobiango","year":"2014","journal-title":"Braz J Infect Dis"},{"key":"R28-20231020","doi-asserted-by":"crossref","first-page":"e58872","DOI":"10.1371\/journal.pone.0058872","article-title":"Protein malnutrition induces bone marrow mesenchymal stem cells commitment to adipogenic differentiation leading to hematopoietic failure.","volume":"8","author":"Cunha","year":"2013","journal-title":"PLoS One"},{"key":"R29-20231020","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.seminhematol.2013.06.010","article-title":"Evaluation and management of patients with isolated neutropenia.","volume":"50","author":"Newburger","year":"2013","journal-title":"Semin Hematol"},{"key":"R30-20231020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ajcn\/5.1.14","article-title":"On the pathogenesis of anemias and leukopenias induced by dietary protein deficiency.","volume":"5","author":"Aschkenasy","year":"1957","journal-title":"Am J Clin Nutr"},{"key":"R31-20231020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/pbc.22032","article-title":"Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi.","volume":"53","author":"Isra\u00ebls","year":"2009","journal-title":"Pediatr Blood Cancer"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201712000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T04:15:31Z","timestamp":1697775331000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201712000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001561","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}